Back to Search Start Over

PQ Interval in Patients With Fabry Disease

Authors :
Namdar, Mehdi
Kampmann, Christoph
Steffel, Jan
Walder, Daniel
Holzmeister, Johannes
Lüscher, Thomas Felix
Jenni, Rolf
Duru, Firat
Source :
American Journal of Cardiology. Mar2010, Vol. 105 Issue 5, p753-756. 4p.
Publication Year :
2010

Abstract

Fabry disease (FD) is an X-chromosomal inherited lysosomal storage disease resulting in intracellular storage of globotriaosylceramide. Cardiac involvement is most frequently manifested as left ventricular hypertrophy. However, patients with FD may also have from various conduction abnormalities particularly affecting atrioventricular (AV) conduction. The present study was designed to analyze primarily AV conduction abnormalities on baseline electrocardiograms of patients with FD and to investigate the correlation with echocardiographic findings. Electrocardiograms at rest of 207 patients with FD were compared to echocardiograms. PQ-interval shortening and first-degree AV block could be found in only 29 cases (14%) and 3 cases (1.4%), respectively. No echocardiographic differences could be found in patients with and without PQ-interval shortening, including left ventricular hypertrophy, atrial size, and diastolic parameters. Furthermore, no correlation of the PQ interval with any echocardiographic parameters was detected. There was no difference between men and women in baseline clinical and electrocardiographic parameters. In conclusion, shortening of the PQ interval was not a common electrocardiographic finding in patients newly diagnosed with FD. Furthermore, no correlation with typical echocardiographic findings or disease stage in FD at baseline could be found. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
00029149
Volume :
105
Issue :
5
Database :
Academic Search Index
Journal :
American Journal of Cardiology
Publication Type :
Academic Journal
Accession number :
48412238
Full Text :
https://doi.org/10.1016/j.amjcard.2009.10.056